HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5- hydroxy- 6- (2- (1H- imidazol- 4- yl)ethylamino)cholestan- 3- ol

structure in first source
Also Known As:
5alpha-hydroxy-6beta-(2-(1H-imidazol-4-yl)ethylamino)cholestan-3beta-ol; dendrogenin A
Networked: 15 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Poirot, Marc: 13 articles (01/2021 - 12/2009)
2. Silvente-Poirot, Sandrine: 13 articles (01/2021 - 12/2009)
3. de Medina, Philippe: 8 articles (01/2021 - 12/2009)
4. Serhan, Nizar: 4 articles (10/2020 - 10/2017)
5. Rives, Arnaud: 4 articles (06/2020 - 10/2017)
6. Récher, Christian: 3 articles (10/2020 - 12/2017)
7. Saland, Estelle: 3 articles (10/2020 - 12/2017)
8. Sarry, Jean-Emmanuel: 3 articles (10/2020 - 12/2017)
9. Record, Michel: 3 articles (06/2020 - 11/2016)
10. Segala, Gregory: 3 articles (06/2020 - 01/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
3. Carcinogenesis
4. Neurodegenerative Diseases (Neurodegenerative Disease)
5. Thyroid Neoplasms (Thyroid Cancer)

Related Drugs and Biologics

1. Cholesterol
2. Cholesterol Esters (Cholesteryl Esters)
3. Carcinogens
4. 27-hydroxycholesterol
5. bis(p-chlorophenyl)acetic acid (DDA)
6. Ligands
7. Oxysterols
8. Liver X Receptors
9. 5- hydroxy- 6- (3- (4- aminobutylamino)propylamino)cholest- 7- en- 3- ol
10. Anthracyclines